1995
DOI: 10.1016/0024-3205(95)00262-5
|View full text |Cite
|
Sign up to set email alerts
|

Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: Associated clinical features

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(12 citation statements)
references
References 52 publications
0
12
0
Order By: Relevance
“…No change ([ 14 C]serotonin uptake) [234] Decrease (human platelets, [ 3 H]paroxetine binding) [323,324] Social phobia Platelet studies:…”
Section: Polymorphism Studiesmentioning
confidence: 99%
“…No change ([ 14 C]serotonin uptake) [234] Decrease (human platelets, [ 3 H]paroxetine binding) [323,324] Social phobia Platelet studies:…”
Section: Polymorphism Studiesmentioning
confidence: 99%
“…Alternatively, a traumatic experience such as sexual abuse may result in psychobiological dysregulation, which may negatively influence maladaptive behaviours, including disordered eating (23,36). CSA or similar traumas may cause disturbances in the 5‐hydroxytryptamine [5‐HT] pathway (37–39), which has been shown to play a key role in the regulation of eating behaviour (40–42). The role of 5‐HT in the development of obesity, however, awaits further study.…”
Section: Possible Explanations Of the Csa–obesity Relationshipmentioning
confidence: 99%
“…A study of the prolactin response to fenfluramine suggests that subjects with PTSD (five of the eight male subjects had comorbid MDE) have a blunted response compared to normal controls (Davis et al, 1999). Some (Fichtner et al, 1995;Maes et al, 1999), but not all (Cicin-Sain et al, 2000;Maguire et al, 1998), reports regarding paroxetine binding to platelets suggest that binding is decreased in PTSD. Lower serotonin in platelet-poor plasma is reported in chronic PTSD although the frequency of comorbidity with MDE is not described (Spivak et al, 1999).…”
Section: Cortisol Response To Serotonin Release By Fenfluramine In MDmentioning
confidence: 99%